Moarcăs M, Georgescu I C, Brătilă E, Badea M, Cîrstoiu M
Obstetrics and Gynaecology Department, University Emergency Hospital, Bucharest.
Obstetrics and Gynaecology Department, "Sf. Pantelimon" Emergency Hospital.
J Med Life. 2014;7 Spec No. 3(Spec Iss 3):37-9.
Cervical screening by using cytology was proven efficient in reducing the mortality secondary to cervical cancer, but this method has limitations. High risk HPV infection is essential for cervical cancer development so HPV testing is a new tool used for screening patients for cervical neoplasia. HPV testing was proven most useful for women over 30 years old, in cases in which cytology identified ASC-US and after treatment for CIN. This article outlines the clinical significance of HPV-DNA testing for precancerous cervical lesions and the evidence that stands behind these recommendations.
通过细胞学进行宫颈筛查已被证明在降低宫颈癌继发死亡率方面是有效的,但这种方法存在局限性。高危型人乳头瘤病毒(HPV)感染是宫颈癌发生的必要条件,因此HPV检测是用于筛查宫颈肿瘤患者的一种新工具。HPV检测已被证明对30岁以上女性最为有用,适用于细胞学检查发现非典型鳞状细胞不能明确意义(ASC-US)的情况以及宫颈上皮内瘤变(CIN)治疗后。本文概述了HPV-DNA检测对宫颈癌前病变的临床意义以及这些建议背后的证据。